Aethlon Medical, Inc.
AEMD
$0.58
-$0.02-2.63%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -2.07% | 13.63% | -49.12% | -31.61% | -40.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.07% | 13.63% | -49.12% | -31.61% | -40.33% |
| Operating Income | 2.07% | -13.63% | 49.12% | 31.61% | 40.33% |
| Income Before Tax | 69.87% | -15.01% | 47.02% | 31.48% | -157.89% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 69.87% | -15.01% | 47.02% | 31.48% | -157.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 69.87% | -15.01% | 47.02% | 31.48% | -157.89% |
| EBIT | 2.07% | -13.63% | 49.12% | 31.61% | 40.33% |
| EBITDA | 1.93% | -14.42% | 50.41% | 32.55% | 41.33% |
| EPS Basic | 95.66% | 75.61% | 76.78% | 69.24% | 53.55% |
| Normalized Basic EPS | 95.58% | 75.61% | 77.30% | 69.24% | 65.84% |
| EPS Diluted | 95.66% | 75.61% | 76.78% | 69.24% | 53.55% |
| Normalized Diluted EPS | 95.58% | 75.61% | 77.30% | 69.24% | 65.84% |
| Average Basic Shares Outstanding | 593.56% | 371.69% | 128.19% | 122.75% | 455.96% |
| Average Diluted Shares Outstanding | 593.56% | 371.69% | 128.19% | 122.75% | 455.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |